Chantal Pharmaceutical makes announcement.LOS ANGELES--(BUSINESS WIRE)--Nov. 15, 1996--Chantal Pharmaceutical Corp. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CHTLE) today announced that due to a delay in filing its Form 10K for fiscal year ending June 30, 1996, NASDAQ has changed its ticker symbol to CHTLE from CHTL. The filing delay is due to the resignation of Coopers and Lybrand as the company's independent accountants on Aug. 5, 1996, and the subsequent Sept. 16, 1996 retaining of its new independent accounts, BDO Seidman. BDO BDO Big Day Out (Australian music festival) BDO Banco de Oro (Philippines) BDO 1,4-Butanediol BDO British Darts Organisation BDO Block Development Officer BDO Big Dumb Object Seidman's partners and staff are expeditiously working with the company's CFO See Chief Financial Officer. and management to complete this filing. The company, through its New York-based SEC counsel, is in regular communication with NASDAQ. The company intends to report within the allotted time. Chantal Pharmaceutical Corp. and its marketing subsidiary, Chantal Skin Care Corp., have executive offices, telemarketing and warehouse facilities in Los Angeles, with a laboratory in Kaiserslautern, Germany. In addition to marketing the Chantal Ethocyn Skin Care line, the company is engaged in the research and development of products for androgen mediated disorders such as acne, hirsutism Hirsutism Definition Excessive growth of facial or body hair in women is called hirsutism. Description Hirsutism is not a disease. The condition usually develops during puberty and becomes more pronounced as the years go by. , male pattern baldness male pattern baldness n. A progressive, diffuse loss of scalp hair in men that begins in the twenties or early thirties, depends on the presence of the androgenic hormone testosterone, and is caused by a combination of genetic and hormonal factors. , benign prostate hypertrophy and the treatment of certain cancers. CONTACT: Martin E. Janis & Co. Inc. Bev Jedynak, 312/943-1100 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion